All News

A plan to build the science base in European countries that lag behind got under way with the award of the first round of grants to enable young researchers to relocate.

Pharminox Ltd, a private oncology R&D company backed by IP Group, is to carry out joint research into novel small molecule chemotherapeutics with Schering-Plough.

Anglo-Dutch antibody specialist PanGenetics BV has agreed a collaboration with Lay Line Genomics SpA of Rome, Italy, in the field of therapeutic antibodies for the treatment of pain.

Cambridge Biostability, a developer of temperature-stable liquid vaccines, agreed a joint venture with Panacea Biotec of India.

Access to a good university shapes the location of corporate R&D.

Responses to the pre-budget statement offer grudging praise and a few suggestions.

Chinese officials warn that people may be overestimating how much the country spends on R&D.

The European Space Agency wants to increase its interaction with European universities, research institutes and industry.